58,791 Danaher Corporation $DHR Shares Sold by Calamos Wealth Management LLC

Calamos Wealth Management LLC lessened its stake in Danaher Corporation (NYSE:DHR) by 93.1% during the 3rd quarter, HoldingsChannel reports. The firm owned 4,344 shares of the conglomerate’s stock after selling 58,791 shares during the quarter. Calamos Wealth Management LLC’s holdings in Danaher were worth $962,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in DHR. Calamos Advisors LLC increased its stake in shares of Danaher by 0.8% in the 3rd quarter. Calamos Advisors LLC now owns 222,372 shares of the conglomerate’s stock valued at $49,267,000 after purchasing an additional 1,701 shares in the last quarter. Alta Advisers Ltd raised its holdings in Danaher by 86.0% in the 3rd quarter. Alta Advisers Ltd now owns 4,525 shares of the conglomerate’s stock worth $1,003,000 after purchasing an additional 2,092 shares during the period. Legacies Wealth LLC purchased a new position in Danaher during the third quarter worth approximately $83,000. Principle Wealth Partners LLC boosted its position in Danaher by 5.5% during the third quarter. Principle Wealth Partners LLC now owns 5,015 shares of the conglomerate’s stock worth $1,111,000 after purchasing an additional 263 shares in the last quarter. Finally, Kestra Advisory Services LLC grew its holdings in Danaher by 4.9% in the third quarter. Kestra Advisory Services LLC now owns 78,390 shares of the conglomerate’s stock valued at $17,367,000 after purchasing an additional 3,643 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. boosted their price objective on Danaher from $250.00 to $270.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. The Goldman Sachs Group reiterated a “buy” rating and set a $275.00 target price on shares of Danaher in a research report on Thursday, October 22nd. DZ Bank cut shares of Danaher from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 27th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. Finally, Robert W. Baird upped their price objective on shares of Danaher from $246.00 to $254.00 and gave the stock an “outperform” rating in a research report on Thursday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus price target of $242.91.

Insider Transactions at Danaher

In other news, CAO Christopher Bouda sold 7,598 shares of the company’s stock in a transaction on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the sale, the chief accounting officer owned 9,107 shares of the company’s stock, valued at $2,136,137.92. This represents a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 10.80% of the stock is currently owned by company insiders.

Danaher Price Performance

Shares of Danaher stock opened at $230.34 on Friday. The stock has a market capitalization of $162.05 billion, a P/E ratio of 37.70, a PEG ratio of 2.89 and a beta of 0.76. The business has a 50 day simple moving average of $220.27 and a two-hundred day simple moving average of $201.60. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.29.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The firm had revenue of $6.55 billion for the quarter, compared to analyst estimates of $6.56 billion. During the same period in the previous year, the company posted $1.89 earnings per share. The business’s revenue was up 8.3% on a year-over-year basis. As a group, analysts predict that Danaher Corporation will post 8.59 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were issued a $0.40 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is presently 26.19%.

About Danaher

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing.

The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.